Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2009

Harigopal M, Heymann J, Ghosh S, Anagnostou V, Camp RL, Rimm DL. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Breast Cancer Res Treat. 2009;115(1):77-85.

Mosquera J-, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT? Am J Surg Pathol. 2009;33(9):1314-21.

Choueiri TK, Mosquera J-, Hirsch MS. A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib. Clin Genitourin Cancer. 2009;7(3):E93-4.

Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell. 2009;137(6):1001-4.

Jiang J, Parameshwaran K, M Seibenhener L, Kang M-, Suppiramaniam V, Huganir RL, et al. AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. Hippocampus. 2009;19(4):392-406.

Sboner A, Karpikov A, Chen G, Smith M, Mattoon D, Dawn M, et al. Robust-linear-model normalization to reduce technical variability in functional protein microarrays. J Proteome Res. 2009;8(12):5451-64.

Pflueger D, Rickman DS, Sboner A, Perner S, Lafargue CJ, Svensson MA, et al. N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia. 2009;11(8):804-11.

Ransom M, Williams SK, Dechassa ML, Das C, Linger J, Adkins M, et al. FACT and the proteasome promote promoter chromatin disassembly and transcriptional initiation. J Biol Chem. 2009;284(35):23461-71.

Ghosh M, Aguila HL, Michaud J, Ai Y, Wu M-, Hemmes A, et al. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J Clin Invest. 2009;119(12):3530-43.

Nanni S, Benvenuti V, Grasselli A, Priolo C, Aiello A, Mattiussi S, et al. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest. 2009;119(5):1093-108.